发现伊朗癌症研究的主要参与者和重要主题对于伊朗决策者至关重要,临床医生,和研究人员。这项研究旨在展示1960年至2018年伊朗癌症研究的趋势和顶部。
WebofScience(WoS)上共有22,370篇伊朗癌症文章,PubMed,还有Scopus,从1960年到2018年,基于数据挖掘技术进行了提取和预处理,并使用协作网络分析进行了分析,关键词分析,和文献计量学方法。
结果显示,德黑兰医科大学(11.46%)在组织中,亚太癌症预防杂志(5%)作者中的MalekzadehR(1.09%),乳腺癌(10.37%)在主题中排名第一。伊朗癌症研究的趋势代表三个时期:1)发芽期,从1970年到2000年,2)发展时期,从2002年到2014年,以及3)繁荣期,从2014年到2018年。预计这一趋势将继续下去。结果表明,伊朗癌症研究人员每年发表的文章的对数平均增加了12.8%。研究结果与Price的出版物趋势相关,主要用于确定全球和伊朗癌症研究出版物趋势。
伊朗研究人员发表的关于癌症的研究论文数量正在增加。为了保持该领域的出版物增长,建议其他伊朗机构更多地参与。尽管在某些主题中论文的数量和质量正在增加,某些主题和类型的癌症仍需进一步研究,应鼓励伊朗决策者在这些主题上投入更多资金。
BACKGROUND: Detecting the main actors and important topics of Iranian cancer research is essential for Iranian policymakers, clinicians, and researchers. This study was conducted to demonstrate the trends and tops in Iranian cancer research from 1960 to 2018.
METHODS: A total of 22,370 Iranian cancer articles in Web of Science (WoS), PubMed, and Scopus, from 1960 through 2018, were extracted and preprocessed based on data mining techniques and analyzed using the collaboration network analysis, keywords analysis, and bibliometrics methods.
RESULTS: The results reveal that, Tehran University of Medical Sciences (11.46%) among organizations, Asian Pacific Journal of Cancer Prevention (5%) among journals, Malekzadeh R (1.09%) among authors, and Breast cancer (10.37%) among topics ranked the first. The trend of Iranian cancer research represents three periods: 1) germinating period, from 1970 to 2000, 2) developing period, from 2002 to 2014, and 3) flourishing period, from 2014 to 2018. It is expected that this trend will continue. The results indicate an average 12.8% increase in the logarithm of the count of articles published by Iranian cancer researchers each year. The findings are contextualized with Price\'s publications trends principal for determining global and Iranian cancer research publication trends.
CONCLUSIONS: The number of research papers published by Iranian researchers on cancer is increasing. In order to maintain the publication growth in this field, greater participation by other Iranian institutions is suggested. Although the quantity and quality of papers are increasing in some topics, certain topics and types of cancers should be still further studied and the Iranian policymakers should be encouraged to invest more in these topics.